About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The Diabetes and Metabolism Research Group is search is lead by Dr. Rafael Simó (Hirsch index:54), Head of the Endocrinology Department, Professor of Medicine & Endocrinology at UAB and current President of the European Association for the Study of Diabetes-Eye Complications. The group consists of 7 senior clinical investigators, 4 basic post-doctoral researchers, 4 pre-doc researchers, 3 laboratory technicians and one coordinator of clinical assays.
The group belongs to “CIBER” of Diabetes and Associated Metabolic Diseases (CIBERDEM. ISCIII) and has been recognized as consolidated group by the Generalitat de Catalunya (AQU/AGAUR).
Since 2014 this group has been qualified as outstanding in the evaluations performed by the ANEP, CIBERDEM and the external Scientific Advisory Board of VHIR.
The main lines of research are:
PMID: 35403441 Journal: THYROID Year: 2022 Reference: Thyroid. 2022 Jun;32(6):682-693. doi: 10.1089/thy.2021.0694. Epub 2022 May 25. Impact factor: 6.568 Publication type: Paper in international publication Authors: Zafon, Carles, Alvarez de la Sierra, Daniel, Marin-Sanchez, Ana, Gomez-Brey, Aroa, Bello, Irene, Caubet, Enric, Moreno-Llorente, Pablo, Petit, Anna, Pujol-Borrell, Ricardo, Gonzalez, Oscar et al. DOI: 10.1089/thy.2021.0694
PMID: 35363561 Journal: Journal of Laparoendoscopic & Advanced Surgical Te Year: 2022 Reference: J Laparoendosc Adv Surg Tech A. 2022 Apr 1. doi: 10.1089/lap.2021.0863. Impact factor: 1.878 Publication type: Paper in international publication Authors: Ortiz-Zuniga, Angel Michael, Costa Forner, Pilar, Cirera de Tudela, Arturo, Garcia Ruiz, Amador, Comas Martinez, Marta, Palmas, Fiorella, Morer Linan, Carla, Vilallonga, Ramon, Ciudin, Andreea et al. DOI: 10.1089/lap.2021.0863
PMID: 35351135 Journal: BMC Medicine Year: 2022 Reference: BMC Med. 2022 Mar 29;20(1):129. doi: 10.1186/s12916-022-02345-w. Impact factor: 8.775 Publication type: Paper in international publication Authors: Gallo, Monica Martinez, Arrese-Munoz, Iria, Gine, Anna, Diaz-Troyano, Noelia, Gabriel-Medina, Pablo, Riveiro-Barciela, Mar, Labrador-Horrillo, Moises, Martinez-Valle, Fernando, Montalva, Adrian Sanchez, Hernandez-Gonzalez, Manuel et al. DOI: 10.1186/s12916-022-02345-w
PMID: 35256061 Journal: Endocrinologia Diabetes y Nutricion Year: 2022 Reference: Endocrinol Diabetes Nutr (Engl Ed). 2022 Feb;69(2):155-156. doi: 10.1016/j.endien.2022.02.004. Impact factor: 1.417 Publication type: Letter or abstract Authors: Cordero-Vazquez, Efrain, Filippi-Arriaga, Francesca, Hernandez, Irene Hernandez, Haman, Stephanie Solange Tasayco, Ciudin, Andreea et al. DOI: 10.1016/j.endien.2022.02.004
PMID: 33846082 Journal: Endocrinologia Diabetes y Nutricion Year: 2021 Reference: Endocrinol Diabetes Nutr (Engl Ed). 2021 Apr 9. pii: S2530-0164(21)00077-X. doi: 10.1016/j.endinu.2020.11.008. Impact factor: 1.417 Publication type: Letter or abstract Authors: Cordero-Vazquez, Efrain, Filippi-Arriaga, Francesca, Hernandez, Irene Hernandez, Haman, Stephanie Solange Tasayco, Ciudin, Andreea et al. DOI: 10.1016/j.endinu.2020.11.008
PMID: 33796079 Journal: Frontiers in Endocrinology Year: 2021 Reference: Front Endocrinol (Lausanne). 2021 Mar 16;12:648411. doi: 10.3389/fendo.2021.648411. eCollection 2021. Impact factor: 5.555 Publication type: Review in international publication Authors: Puig-Domingo, Manel, Bernabeu, Ignacio, Pico, Antonio, Biagetti, Betina, Gil, Joan, Alvarez-Escola, Cristina, Jorda, Mireia, Marques-Pamies, Montserrat, Soldevila, Berta, Galvez, Maria-Angeles et al. DOI: 10.3389/fendo.2021.648411
PMID: 32423687 Journal: MEDICINA CLINICA Year: 2021 Reference: Med Clin (Barc). 2021 Apr 9;156(7):362-363. doi: 10.1016/j.medcli.2020.01.040. Epub 2020 May 16. Impact factor: 1.725 Publication type: Letter or abstract Authors: Vega-Cano, Sharela, Cordero-Vazquez, Efrain, Mestre-Torres, Jaume et al. DOI: 10.1016/j.medcli.2020.01.040
PMID: 33085039 Journal: Pituitary Year: 2021 Reference: Pituitary. 2021 Apr;24(2):146-158. doi: 10.1007/s11102-020-01092-6. Epub 2020 Oct 21. Impact factor: 4.107 Publication type: Review in international publication Authors: Biagetti, Betina, Aulinas, Anna, Casteras, Anna, Perez-Hoyos, Santiago, Simo, Rafael et al. DOI: 10.1007/s11102-020-01092-6
The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.
This investment from EIT Health in the project will enable D-Sight to progress in the clinical development of its groundbreaking treatment for the early stages of diabetic retinopathy.
This initiative of the ”la Caixa” Foundation offers the selected entrepreneurial scientists financial support and support through individual mentoring and training.
